Multiple sclerosis relapse prophylaxis

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
0 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
BTK inhibitor 1 substance
Phase III: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase III

1 trial
  • Region Stockholm – SLSO Academic
    TOLEBRUTINIB
    2025-523892-50-00 1 country n=60
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Region Stockholm – SLSO Academic 1 Phase III 0
← All indication landscapes